BG104915A - Azabicyclic 5hti receptor ligands - Google Patents

Azabicyclic 5hti receptor ligands

Info

Publication number
BG104915A
BG104915A BG104915A BG10491500A BG104915A BG 104915 A BG104915 A BG 104915A BG 104915 A BG104915 A BG 104915A BG 10491500 A BG10491500 A BG 10491500A BG 104915 A BG104915 A BG 104915A
Authority
BG
Bulgaria
Prior art keywords
azabicyclic
receptor ligands
5hti
5hti receptor
compounds
Prior art date
Application number
BG104915A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gene BRIGHT
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG104915A publication Critical patent/BG104915A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
BG104915A 1998-04-09 2000-11-07 Azabicyclic 5hti receptor ligands BG104915A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8123798P 1998-04-09 1998-04-09
PCT/IB1999/000457 WO1999052907A1 (en) 1998-04-09 1999-03-18 Azabicyclic 5ht1 receptor ligands

Publications (1)

Publication Number Publication Date
BG104915A true BG104915A (en) 2001-07-31

Family

ID=22162936

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104915A BG104915A (en) 1998-04-09 2000-11-07 Azabicyclic 5hti receptor ligands

Country Status (40)

Country Link
US (2) US6525048B1 (is)
EP (1) EP1070065B1 (is)
JP (1) JP3496759B2 (is)
KR (1) KR100378931B1 (is)
CN (1) CN1117092C (is)
AP (1) AP1175A (is)
AR (1) AR015751A1 (is)
AT (1) ATE248838T1 (is)
AU (1) AU749254B2 (is)
BG (1) BG104915A (is)
BR (1) BR9909522A (is)
CA (1) CA2327782A1 (is)
CO (1) CO5080727A1 (is)
CZ (1) CZ20003684A3 (is)
DE (1) DE69910997T2 (is)
DK (1) DK1070065T3 (is)
DZ (1) DZ2756A1 (is)
EA (1) EA003400B1 (is)
ES (1) ES2204154T3 (is)
HR (1) HRP20000653A2 (is)
HU (1) HUP0102400A3 (is)
ID (1) ID26086A (is)
IL (1) IL138629A0 (is)
IS (1) IS5641A (is)
MA (1) MA26619A1 (is)
MY (1) MY133390A (is)
NO (1) NO20005004L (is)
NZ (1) NZ507010A (is)
OA (1) OA11496A (is)
PA (1) PA8469101A1 (is)
PE (1) PE20000413A1 (is)
PL (1) PL343408A1 (is)
PT (1) PT1070065E (is)
SK (1) SK14782000A3 (is)
TN (1) TNSN99056A1 (is)
TR (1) TR200002932T2 (is)
TW (1) TW555758B (is)
WO (1) WO1999052907A1 (is)
YU (1) YU59400A (is)
ZA (1) ZA992596B (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en) 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
EA004101B1 (ru) 1999-09-03 2003-12-25 Эли Лилли Энд Компани Применение селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
DE60229123D1 (de) * 2001-02-20 2008-11-13 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
JP3910627B2 (ja) * 2003-03-12 2007-04-25 ファイザー・プロダクツ・インク ピリジルオキシメチルおよびベンゾイソオキサゾールのアザビシクロ環の誘導体
JP2007519705A (ja) * 2004-01-29 2007-07-19 ファイザー・プロダクツ・インク Ｃｎｓ障害を治療するための非定型抗精神病薬とアミノメチルピリジルオキシメチル／ベンゾイソオキサゾールアザビシクロ誘導体の組合せ
JP4559749B2 (ja) * 2004-02-16 2010-10-13 あすか製薬株式会社 ピペラジニルピリジン誘導体
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
JP2008503560A (ja) * 2004-06-22 2008-02-07 ファイザー・プロダクツ・インク ジアザビシクロ系のヒスタミン−３受容体アンタゴニスト
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
WO2006027692A2 (en) * 2004-09-10 2006-03-16 Pfizer Products Inc. Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
RU2417082C2 (ru) * 2009-07-14 2011-04-27 Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106849A (en) * 1988-05-24 1992-04-21 American Home Products Corporation Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5565453A (en) * 1991-09-25 1996-10-15 Pfizer Inc. Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
US5262428A (en) * 1992-03-13 1993-11-16 Wake Forest University Biologically active tropane derivatives
WO1993025552A1 (en) * 1992-06-16 1993-12-23 Pfizer Inc. Process and intermediates for bis-aza-bicyclic anxiolytic agents
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
ATE248838T1 (de) 2003-09-15
HRP20000653A2 (en) 2001-04-30
BR9909522A (pt) 2000-12-19
ID26086A (id) 2000-11-23
JP2002511469A (ja) 2002-04-16
IS5641A (is) 2000-09-26
TW555758B (en) 2003-10-01
NO20005004L (no) 2000-11-27
YU59400A (sh) 2003-10-31
US20030181458A1 (en) 2003-09-25
US6525048B1 (en) 2003-02-25
EA200000910A1 (ru) 2001-04-23
HUP0102400A3 (en) 2002-10-28
KR20010042527A (ko) 2001-05-25
CZ20003684A3 (cs) 2002-03-13
AU3268799A (en) 1999-11-01
PL343408A1 (en) 2001-08-13
DK1070065T3 (da) 2003-11-24
DE69910997D1 (de) 2003-10-09
ES2204154T3 (es) 2004-04-16
NO20005004D0 (no) 2000-10-04
WO1999052907A1 (en) 1999-10-21
US6887905B2 (en) 2005-05-03
EP1070065B1 (en) 2003-09-03
CN1117092C (zh) 2003-08-06
HK1035719A1 (en) 2001-12-07
AP9901502A0 (en) 1999-06-30
AP1175A (en) 2003-06-04
DZ2756A1 (fr) 2003-09-15
KR100378931B1 (ko) 2003-04-07
NZ507010A (en) 2003-05-30
CN1305477A (zh) 2001-07-25
CO5080727A1 (es) 2001-09-25
ZA992596B (en) 2000-10-08
JP3496759B2 (ja) 2004-02-16
HUP0102400A2 (hu) 2001-11-28
EA003400B1 (ru) 2003-04-24
IL138629A0 (en) 2001-10-31
CA2327782A1 (en) 1999-10-21
PA8469101A1 (es) 2000-09-29
SK14782000A3 (sk) 2002-06-04
TR200002932T2 (tr) 2001-01-22
AU749254B2 (en) 2002-06-20
PE20000413A1 (es) 2000-05-25
OA11496A (en) 2004-05-14
MY133390A (en) 2007-11-30
PT1070065E (pt) 2003-12-31
EP1070065A1 (en) 2001-01-24
TNSN99056A1 (fr) 2005-11-10
DE69910997T2 (de) 2004-05-19
MA26619A1 (fr) 2004-12-20
AR015751A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
BG104915A (en) Azabicyclic 5hti receptor ligands
BG102704A (en) Fungicide 2-methoxybenzophenons
BG103485A (en) Ketobanzamides as calpain inhibitors
BG105557A (en) Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
GB9722520D0 (en) Compounds
BG105028A (en) Bridged indenopyrrolocarbazoles
TR200103273T2 (tr) Hemisentetik yöntem ve yeni bileşimler.
CA2341291A1 (en) Pyridine ketones useful as herbicides
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BG105711A (en) 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
BG92804A (bg) 4-бензоилизоксазолови производни
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
WO2001017973A3 (de) Neue herbizide
PL335699A1 (en) Tetrahydropyridic compounds
BG105847A (en) Calcilytic compounds
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
MXPA02009549A (es) Imidazopiridinas triciclicas.
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
IN187760B (is)
BG106002A (en) Process for preparing pesticidal intermediates
CA2281702A1 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
ZA976481B (en) Intermediates for the preparation of 2-imidazolin-5-ones.
IL138638A0 (en) Processes for preparing intermediates